Observational evidence shows glycemic control may slow cognitive decline in older adults with type 2 diabetes, indicating potential benefits of GLP-1RAs.
Our findings suggest that improved glycemic control may help slow cognitive decline in older patients with T2DM. Among the drug classes examined, GLP-1RAs showed the largest reductions in HbA1c and were linked to greater MMSE score gains.
No takes yet. Share an insight, caveat, or question.
Marzio et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: